touchpodcast
touchPODCAST
Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005!We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healthcare Professionals globally, by translating published data into easily digestible and timely updatesHome...
Author
touchpodcast
Category
Podcast website
Latest episode
Jul 9, 2026
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Episodes
MDT and patient advocate perspectives on what can be learned from patients with CML 09.05.2022 14:03
touchMDT for touchONCOLOGY Listen to key experts from a multidisciplinary team, plus a patient advocate, consider real-life perspectives from patients with chronic myeloid leukaemia, and what HCPs can learn from them to improve outcomes The multidisciplinary team Haematologist: Prof. Dr med. Andreas Hochhaus, Germany Patient advocate: Jelena Čugurović, Serbia Nurse specialist: Johan De Munter, Be...
Extending the benefit of PARP inhibitors through combinations for advanced prostate cancer - Conversation 3 05.05.2022 12:06
touchMDT for touchONCOLOGY Listen to a medical oncologist, a urologist and an oncology pharmacist discuss extending the benefit of PARP inhibitors through combinations for the treatment of advanced prostate cancer. The multidisciplinary team Medical Oncologist: Dr Wassim Abida, USA Urologist: Professor Axel Merseburger, Germany Oncology Pharmacist: Dr Lisa Holle, USA This touchPODCAST is for HCP...
PARP inhibitor combination clinical trials for advanced prostate cancer - Conversation 2 05.05.2022 12:15
touchMDT for touchONCOLOGY Listen to a urologist and a medical oncologist discuss key clinical trials investigating PARP inhibitor combinations for the treatment of advanced prostate cancer. The multidisciplinary team Urologist: Professor Axel Merseburger, Germany Medical Oncologist: Dr Wassim Abida, USA This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent me...
Rationale for PARP inhibitor combinations for advanced prostate cancer - Conversation 1 05.05.2022 12:35
touchMDT for touchONCOLOGY Listen to an oncology pharmacist and a medical oncologist discuss the rationale for PARP inhibitors for the treatment of advanced prostate cancer. The multidisciplinary team Oncology Pharmacist: Dr Lisa Holle, USA Medical Oncologist: Dr Wassim Abida, USA This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant f...
ENT experts discuss minimizing the clinical burden of chronic rhinosinusitis with nasal polyposis 27.04.2022 36:17
touchIN CONVERSATION for touchRESPIRATORY Listen to Professor Valerie Lund in conversation with Dr Sietze Reitsma. They respond to questions submitted by the HCP audience and provide their expert insights on the key considerations for minimizing the clinical burden of chronic rhinosinusitis with nasal polyposis. This touchPODCAST is for HCPs only. This activity is funded by an unrestricted indepen...
ENT experts discuss minimizing the clinical burden of chronic rhinosinusitis with nasal polyposis 27.04.2022 36:18
touchIN CONVERSATION for touchIMMUNOLOGY Listen to Professor Valerie Lund in conversation with Dr Sietze Reitsma. They respond to questions submitted by the HCP audience and provide their expert insights on the key considerations for minimizing the clinical burden of chronic rhinosinusitis with nasal polyposis. This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independ...
Considerations for the selection of disease-modifying treatments in SMA: A case-based discussion 27.04.2022 36:57
touchPANEL DISCUSSION for touchNEUROLOGY Listen as three experts in spinal muscular atrophy (SMA) discuss factors influencing treatment decision-making with approved SMA therapies using patient case studies. The experts Prof. Eugenio Mercuri – Policlinico Universitario Agostino Gemelli, Rome, Italy Prof. Nathalie Goemans – UZ Leuven, Leuven, Belgium Prof. Dr. med. Tim Hagenacker – Essen University...
Improving patient outcomes in relapsing MS: Current oral DMTs and emerging therapies 26.04.2022 30:11
touchTALKS for touchNEUROLOGY Listen to a leading expert in multiple sclerosis (MS) discuss how disease-modifying therapies are currently used in clinical practice for the optimal management of relapsing MS. Prof. Patricia K Coyle highlights the importance of reducing the burden of the often ‘invisible’ symptoms of MS, such as fatigue, on overall patient quality of life, and reviews the latest, p...
PARP inhibitors as first-line maintenance therapy in ovarian cancer: Update from SGO 2022 20.04.2022 57:52
touchCONGRESS for touchONCOLOGY Listen to Prof. Isabelle Ray-Coquard (France) cover key data presented at SGO 2022 on PARP inhibitors as first-line maintenance therapy in ovarian cancer, and their implications for clinical practice, including expert insights and interpretation from Dr Antonio González-Martín (Spain) and Dr Sandro Pignata (Italy). OVERVIEW Data review with Prof. Ray-Coquard (0:32)...
MDT discussions on the rationale for using GLP-1 as a therapeutic target in T2D 14.04.2022 13:52
touchMDT for touchENDOCRINOLOGY Listen to key experts from a multidisciplinary team review the rationale for using GLP-1 as a therapeutic target in T2D and provide an overview of GLP-1 RA based therapies The multidisciplinary team Primary Care Physician: Dr Kevin Fernando, Berwick, UK Endocrinologist: Prof. Dr med. Michael Nauck, Bochum, Germany This touchPODCAST is for HCPs only. This activity i...
MDT and patient perspectives on the safety of GLP-1 RAs and managing their side effects 14.04.2022 15:58
touchMDT for touchENDOCRINOLOGY Listen to key experts from a multidisciplinary team and a patient explore the safety of GLP-1 RAs and the role of patient education in managing the side effects of these agents The multidisciplinary team and patient Primary Care Physician: Dr Kevin Fernando, Berwick, UK Diabetes Nurse Specialist: Prof. Dr Şeyda Özcan, Istanbul, Turkey Patient Advocate: Ms Kelly Ann...
MDT and patient perspectives on the role of GLP-1 RAs in the T2D management pathway 14.04.2022 13:47
touchMDT for touchENDOCRINOLOGY Listen to key experts from a multidisciplinary team and a patient explore the role of GLP-1 RAs in the T2D management pathway, real-world factors affecting selection of a GLP-1 RA, and how GLP-1 RA therapy has influenced real-life patients in their glycemic and weight-loss goals The multidisciplinary team and patient Endocrinologist: Prof. Dr med. Michael Nauck, Boc...
Improving patient outcomes in moderate-to-severe ulcerative colitis 13.04.2022 25:52
touchEXPERT OPINIONS for touchIMMUNOLOGY Listen to leading experts discuss important considerations in the optimal management of patients with moderate-to-severe ulcerative colitis. The experts Prof. Ailsa Hart – St Mark’s Hospital and Academic Institute, London, UK Dr Gil Y Melmed – Inflammatory Bowel Disease Center, Cedars-Sinai Medical Center, Los Angeles, CA, USA Prof. Brian G Feagan – Univers...
AAAAI 2022: Improving outcomes for patients with eosinophilic esophagitis 12.04.2022 1:02:49
touchCONGRESS for touchRESPIRATORY Listen to Dr Evan Dellon (USA) cover key data presented at AAAAI 2022 Annual Meeting on eosinophilic esophagitis (EoE) including risk factors and pathogenesis, burden of disease and emerging treatment options, as well as expert insights and interpretation from Dr Stuart Carr (Abu Dhabi, UAE) and Dr Alexandra Papadopoulou (Greece). Overview Data review with Dr Eva...
AAAAI 2022: Improving outcomes for patients with eosinophilic esophagitis 12.04.2022 1:02:48
touchCONGRESS for touchRESPIRATORY Listen to Dr Evan Dellon (USA) cover key data presented at AAAAI 2022 Annual Meeting on eosinophilic esophagitis (EoE) including risk factors and pathogenesis, burden of disease and emerging treatment options, as well as expert insights and interpretation from Dr Stuart Carr (Abu Dhabi, UAE) and Dr Alexandra Papadopoulou (Greece). Overview Data review with Dr Eva...
Unlocking CSU pathogenesis to shape the future treatment landscape 11.04.2022 38:22
touchPANEL DISCUSSION for touchIMMUNOLOGY Listen to a panel of experts discuss how emerging endotypes in chronic spontaneous urticaria are driving the development of much-needed new treatment and management approaches. The experts: Prof. Dr med. Marcus Maurer – Charité University Medicine, Berlin, Germany Dr Melinda Gooderham – SKiN Centre for Dermatology, Ontario, Canada Prof. David Khan – Southw...
Identifying, diagnosing and treating patients with later-onset SMA 06.04.2022 35:17
touchTALKS for touchRESPIRATORY Listen to Dr Parsons of the University of Colorado, Aurora, CO, USA, describe the clinical presentation and diagnosis of later-onset phenotypes of SMA, before reviewing clinical trial data for approved treatments and assessing their impact on the natural history of the disease. This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independe...
Identifying, diagnosing and treating patients with later-onset SMA 05.04.2022 35:19
touchTALKS for touchNEUROLOGY Listen to Dr Parsons of the University of Colorado, Aurora, CO, USA, describe the clinical presentation and diagnosis of later-onset phenotypes of SMA, before reviewing clinical trial data for approved treatments and assessing their impact on the natural history of the disease. This touchPODCAST is for HCPs only This activity is funded by an unrestricted independent...
The relationship between people living with HIV and their multidisciplinary team for optimal adherence to ART 04.04.2022 13:32
touchMDT for touchINFECTIOUSDISEASES Listen to an HIV specialist, a specialist nurse and an advocate for PLHIV discuss the important role of the multidisciplinary team in optimizing adherence to ART and health of PLHIV The experts HIV Specialist: Dr Laura Waters, London, UK Nurse Specialist; Ms Catarina Esteves, Cascais, Portugal Advocate for PLHIV: Ms Susan Cole, London, UK This touchPODCAST is f...
Long-term ART adherence, comorbidities and quality of life for people living with HIV 04.04.2022 15:01
touchMDT for touchINFECTIOUSDISEASES Listen to an HIV specialist, a specialist nurse and an advocate for PLHIV discuss factors impacting quality of life and adherence to ART in PLHIV. The multidisciplinary team HIV Specialist: Dr Laura Waters, London, UK Nurse Specialist; Ms Catarina Esteves, Cascais, Portugal Advocate for PLHIV: Ms Susan Cole, London, UK This touchPODCAST is for HCPs only. This...
Assessing readiness to initiate ART to maximize adherence 04.04.2022 13:41
touchMDT for touchINFECTIOUSDISEASES Listen to an HIV specialist, a specialist nurse and a clinical pharmacist discuss how they assess readiness to start ART and barriers to adherence. The multidisciplinary team HIV Specialist: Dr Laura Waters, London, UK Nurse Specialist; Ms Catarina Esteves, Cascais, Portugal Clinical Pharmacist: Ms Fiona Marra, Glasgow, UK This touchPODCAST is for HCPs only. ...
Overcoming barriers to PrEP to optimize uptake and adherence 04.04.2022 14:12
touchMDT for touchINFECTIOUSDISEASES Listen to an HIV specialist and clinical pharmacist discuss PrEP and how factors affecting adherence may be overcome in different populations at risk of HIV infection. The multidisciplinary team HIV Specialist: Dr Laura Waters, London, UK Clinical Pharmacist: Ms Fiona Marra, Glasgow, UK This touchPODCAST is for HCPs only. This activity is funded by an unres...
Sharing data to improve outcomes in LACC: What’s on the horizon? 31.03.2022 12:12
touchMDT for touchONCOLOGY Listen to a gynaecologic oncologist, a clinical oncologist, and a radiation oncologist discuss the role of the MDT in implementing change to best practice care and the importance of keeping up to date with the latest clinical trial data. The multidisciplinary team Gynaecologic oncologist: Prof. Bradley Monk, USA Clinical oncologist: Dr Mary McCormack, UK Radiation oncolo...
MDT: Current treatment of LACC: Where are we now? 31.03.2022 13:09
touchMDT for touchONCOLOGY Listen to a clinical oncologist and a radiation oncologist discuss current treatment approaches for patients with locally advanced cervical cancer using a patient case to illustrate best practice with the standard of care; ongoing clinical trials are also highlighted. The multidisciplinary team Clinical oncologist: Dr Mary McCormack, UK Radiation oncologist: Prof. Cyrus...
MDT: Optimizing the patient journey in LACC: Can we reduce the burden? 31.03.2022 10:26
touchMDT for touchONCOLOGY Listen to a gynaecologic oncologist and nurse practitioner discuss the prognostic risk factors for patients with LACC and how best to support patients throughout their treatment journey for optimal outcomes. The multidisciplinary team Gynaecologic oncologist: Prof. Bradley Monk, USA Nurse practitioner: Ms Kathleen Smith, USA This touchPODCAST is for HCPs only. This activ...
Similar podcasts
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.